{"id":"W2344740792","doi":"10.1056/nejmoa1502924","title":"Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":413,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Universitätsklinikum Hamburg-Eppendorf; Public Health Agency; Public Health Agency of Canada; Hôpitaux Universitaires de Genève; Philipps-Universität Marburg; Wellcome Trust; Clinical Trial Center, China Medical University Hospital","keywords":"Medicine; Immunogenicity; Ebola vaccine; Virology; Viremia; Reactogenicity; Ebola virus; Neutralizing antibody; Titer; Immunology; Vaccination; Antibody; Ebolavirus; Adverse effect; Virus; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1727780333729772,"score_gpt":0.4242541080335178,"score_spread":0.2514760746605406,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}